-+ 0.00%
-+ 0.00%
-+ 0.00%

REVIVA ANNOUNCES REGULATORY UPDATE REGARDING THE DEVELOPMENT OF BRILAROXAZINE FOR THE TREATMENT OF SCHIZOPHRENIA

路透·12/23/2025 13:00:04

登录查看新闻详情